EINSPRITZVORRICHTUNG

Patent europeic · EP3551255 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3551255
Numer da la dumonda
EP17804924
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
04-12-2017
Publitgà
16-10-2019
Concedì
27-07-2022
La protecziun finescha il pli tard
03-12-2037
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61M 5/32 (2006.01)
A61M 5/20 (2006.01)
Prioritad
EP 16202659 07.12.2016
Dumonda PCT
PCT/EP2017/081309 04.12.2017
Publicaziun PCT
WO2018/104203 14.06.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 07-06-2023

    Midada

    Published in Swissreg on 07.06.2023

  5. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  6. 27-07-2022

    Concedì

    Published in Swissreg on 27.07.2022

Partidas

Possessur

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65926 Frankfurt am Main, DE

Inventur

RAU, Matthias

65195 Wiesbaden, DE

NOBER, Peter

54597 Rommersheim, DE

THEYSEN, David

55116 Mainz, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.